vimarsana.com
Home
Live Updates
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q4 2023 Earnings Call Transcript : vimarsana.com
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q4 2023 Earnings Call Transcript : vimarsana.com
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q4 2023 Earnings Call Transcript
Kymera Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.25, expectations were $-0.44.
Related Keywords
United States ,
Watertown ,
Massachusetts ,
American ,
Bruce Jacobs ,
Vikram Purohit ,
Jared Gollob ,
Michael Schmidt ,
Justine Koenigsberg ,
Nello Mainolfi ,
Morgan Stanley ,
American Academy Of Dermatology Annual Meeting ,
Most Valuable Logistics Companies ,
Nasdaq ,
Most Valuable Insurance Companies ,
Kymera Therapeutics Inc ,
Kymera Therapeutics ,
Call Transcript February ,
Kymera Therapeutics Fourth Quarter ,
Chief Medical Officer ,
Chief Financial ,
Immunology Rd Day ,
American Academy ,
Dermatology Annual Meeting ,
Valuable Insurance Companies ,
Valuable Logistics Companies ,